Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.22.1
Stockholders’ Equity (Tables)
 3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]  
Schedule of warrant and stock option grants with time-based vesting
    Warrant Grants     Stock Option Grants     Restricted Stock Units  
   

Number of

shares
subject to warrants

     Weighted-
average
exercise
price per
share		     Number of
shares
subject to
options		     Weighted-
average
exercise
price per
share		     Number of
shares
subject to
restricted
stock units		  
Balance at December 31, 2021     1,043,525     $ 2.57       118,388     $ 3.25       2,160,757  
Granted    
-
      
-
      
-
      
-
       443,954  
Exercised    
-
      
-
      
-
      
-
       (102,620 )
Cancelled/Expired    
-
      
-
      
-
      
-
      
-
  
Balance at March 31, 2022     1,043,525     $ 2.57       118,388     $ 3.25       2,502,091  
Exercisable at March 31, 2022     1,043,525     $ 2.57       118,388     $ 3.25       1,802,299  

Schedule of company’s outstanding warrants and options
Warrants Outstanding   Warrants Exercisable
Exercise Price Range   Number
Outstanding		     Weighted Average
Remaining
Contractual Life
(in years)		    

Weighted

Average
Exercise Price

     Number Exercisable   Weighted Average Exercise Price     Intrinsic Value  
$1.79 - $20.90     1,043,525       2.74     $ 2.57     1,043,525   $ 2.57      
-
  

Options Outstanding   Options Exercisable
Exercise Price Range   Number
Outstanding		     Weighted Average
Remaining
Contractual Life
(in years)		     Weighted Average
Exercise Price		     Number
Exercisable		   Weighted Average
Exercise Price		     Intrinsic Value  
$2.64 - $28.50     118,388       2.44     $ 3.25     118,388   $ 3.25      
-
  

 
Schedule of stock-based compensation expense
    For the three months ended  
    March 31,  
    2022     2021  
Stock-based compensation expense   $ 347,568     $ 500,718  

 
Schedule of stock-based compensation expense categorized by the equity components
    For the three months ended  
    March 31,  
    2022     2021  
Common stock   $ 347,568     $ 500,718  
Total   $ 347,568     $ 500,718